Do you know a precision medicine champion?


The future of precision medicine depends on those who believe in its potential—whether they are providers, researchers, pathologists, genomicists, payers, molecular lab employees or patients.

If you or someone you know took a chance to move precision medicine forward, let us know, so we can all benefit from their insight. 

Trapelo is the first, single technology platform used by oncologists, labs and payors that streamlines workflow and facilitates real-time alignment in precision medicine. Trapelo obviates the need for traditional prior authorization, enabling value-based care while quickly giving patients the most appropriate, evidence-supported options when time matters most.

Trapelo knows:

Which patients to test, which panels to order, and which labs to use
For Oncologists
How to standardize value-based precision medicine across the practice
For Practices
How to drive volume and enhance reimbursement
For Labs
Which tests and treatments are evidence-supported and should be reimbursed
For Payers

Trapelo knows.

How can we resolve the complexities of using precision medicine for cancer care?


Premiere Episodes Live!

Dr. Tony Magliocco, H. Lee Moffitt Cancer Center
Dr. Dave Messina, Cofactor Genomics

Ms. Hannah Mamuszka, Alva 10

PHONE  617.250.7572

FAX  888.972.5991


800 District Ave, Suite 310
Burlington, MA 01803

Google Map »


Copyright 2019 Intervention Insights. All rights reserved. Privacy Policy